Recon: FDA looks to remove ingestible fluoride products from the market; ITeos and GSK halt developing lung cancer therapy

• US FDA aims to remove fluoride supplements for children from market (Reuters) (FDA)
• Our biggest burning questions on Trump’s order to bring down drug prices (STAT)
• US senator calls for stronger ethics commitments from Trump deputy health secretary pick (Reuters)
• Bayer: U.S. Supreme Court could decide in June whether it will hear glyphosate case (Reuters)
• US Medicare lays out timeline for third round of drug price negotiations (Reuters)
• Why Trump’s Drug Price Order Didn’t Rattle the Industry (Bloomberg)
• Measles cases in Texas rise by eight to 717, state health department says (Reuters)

• India's GlaxoSmithKline Pharma reports profit rise on strong demand (Reuters)
• India's Cipla beats quarterly profit, banks on new drug launches for growth (Reuters)
• Industry On Making England’s HTA Innovation Lab A Success (Pink Sheet)
• UK Medtech Regulators Must Ensure Certainty So Businesses Can Plan Their Futures (MedTech Insight)
• Swiss Outlook Cut at UBS With Warning on Trump’s Pharma Push (Bloomberg)

• Investment firm RA Capital lays off incubator staff amid industry instability, push into China (STAT)
• To understand why investors rejoiced at Trump’s attack on drug firms, think like a pharma CEO (STAT)
• Hinge Health targets $2.6 billion valuation as IPO markets signal comeback (Reuters)
• ITeos, GSK discontinue lung cancer therapy development (Reuters)
• Updated: To spin off or not to spin off? Galapagos backpedals on separation plans, CEO Paul Stoffels exits early (Endpoints)
• Arcturus to prioritize mRNA therapeutics in bid to boost rare disease programs (Endpoints)

• OpenAI leaps into health care with AI benchmark to evaluate models (STAT)
• Elizabeth Holmes rises again — or at least her partner does (STAT)
• Roche plans $550M expansion of Indianapolis site to manufacture CGMs (MedTech Dive)
• ‘Pathologists Are Hungry For AI-Enabled Digital Pathology’ (MedTech Insight)
• Physio App Maker Hinge Health, Backers Seek $437 Million IPO (Bloomberg)

• Why new wellness-branded energy drinks have health experts worried (STAT)
• Danone brings Oikos into the $7 billion protein shake market (Food Dive)
• Judge Orders Most Agencies to Pause Mass Layoffs for at Least Two Weeks (Food Safety)
• Post Holdings sees tariffs slowing ‘active M&A pipeline’ (Food Business News)

• Andrew Witty steps down as UnitedHealth CEO (MedTech Dive) (STAT)
• Opinion: Why Casey Means could be the right pick for surgeon general (STAT)
• ‘What do we do with uncertainty?’ A former CDC director’s advice to new physicians and scientists (STAT)